Actinium Appoints Dr. Matt David as CFO
Actinium Pharmaceuticals announced the appointment of Matt David, M.D., as Chief Financial Officer to lead finance and capital markets functions. This strategic leadership addition may enhance investor relations as the company advances its targeted radiotherapy pipeline.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed